Schizophrenia during the COVID-19 pandemic
Clinicians should inform and educate their patients on the risks related to SARS-CoV-2
infection and COVID-19 and on the precautions that they should adopt to avoid contagion …
infection and COVID-19 and on the precautions that they should adopt to avoid contagion …
Implications of the COVID-19 pandemic for patients with schizophrenia spectrum disorders: narrative review
N Zhand, R Joober - BJPsych open, 2021 - cambridge.org
BackgroundCOVID-19 was declared a pandemic in March 2020, by the World Health
Organization. The pandemic has had unprecedented worldwide implications, in particular …
Organization. The pandemic has had unprecedented worldwide implications, in particular …
The effect of longer dosing intervals for long-acting injectable antipsychotics on outcomes in schizophrenia
R Milz, C Benson, K Knight, J Antunes… - Neuropsychiatric …, 2023 - Taylor & Francis
Medication nonadherence in schizophrenia can have serious implications including
relapses and hospitalization. Long-acting injectable (LAI) antipsychotics require fewer …
relapses and hospitalization. Long-acting injectable (LAI) antipsychotics require fewer …
Psychosocial effects of the COVID-19 pandemic on patients with schizophrenia and their caregivers
A Caqueo-Urízar, A Urzúa, F Ponce-Correa… - Frontiers in …, 2021 - frontiersin.org
The aim of this study was to analyze the psychosocial effects of the COVID-19 pandemic on
120 patients with schizophrenia, and their caregivers (control group), in the city of Arica …
120 patients with schizophrenia, and their caregivers (control group), in the city of Arica …
Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study
KA McKee, CE Crocker, PG Tibbo - BMC psychiatry, 2021 - Springer
Background The COVID-19 pandemic has had significant impacts on how mental health
services are delivered to patients throughout Canada. The reduction of in-person healthcare …
services are delivered to patients throughout Canada. The reduction of in-person healthcare …
[HTML][HTML] Long acting injectable antipsychotic medications: ensuring care continuity during the COVID-19 pandemic restrictions
JM Gannon, J Conlogue, R Sherwood… - Schizophrenia …, 2020 - ncbi.nlm.nih.gov
The COVID-19 pandemic has brought significant challenges to clinics specializing in the
care of patients with serious mental illness (SMI). Our ambulatory clinic, Comprehensive …
care of patients with serious mental illness (SMI). Our ambulatory clinic, Comprehensive …
The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance …
CU Correll, C Chepke, P Gionfriddo, J Parks… - BMC psychiatry, 2022 - Springer
Background Long-acting injectable antipsychotics (LAIs) are an essential maintenance
treatment option for individuals with schizophrenia or bipolar I disorder (BP-I). This report …
treatment option for individuals with schizophrenia or bipolar I disorder (BP-I). This report …
Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
The COVID-19 pandemic is having an important impact on the practice of mental health
services and on schizophrenia patients, and heterogeneous and conflicting findings are …
services and on schizophrenia patients, and heterogeneous and conflicting findings are …
Impact of COVID-19 pandemic on prescribing of long-acting injectable antipsychotics for schizophrenia: results from a United States prescriber survey
M Zhdanava, HL Starr, TI Totev, P Lefebvre… - Neuropsychiatric …, 2022 - Taylor & Francis
Purpose To describe changes due to the COVID-19 pandemic in the prescribing of long-
acting antipsychotics (LAI) for schizophrenia, patient outcomes, and patient and healthcare …
acting antipsychotics (LAI) for schizophrenia, patient outcomes, and patient and healthcare …
[HTML][HTML] From predictions to evidence: Treatment compliance, disease progression and social compliance of patients with schizophrenia in the COVID‐19 pandemic
From predictions to evidence: Treatment compliance, disease progression and social
compliance of patients with schizophrenia in the COVID‐19 pandemic - PMC Back to Top Skip …
compliance of patients with schizophrenia in the COVID‐19 pandemic - PMC Back to Top Skip …